You have been chosen to receive this valuable information.
SMi Group presents their inaugural........
Wearable Injectors &
Connected Devices
9th & 10th October 2019, Copthorne Tara Hotel, Kensington, London, UK
Proudly sponsored by: Schott & Mikron

 
£400 early bird ends 31st May - Register today!

Dear %%firstname%%,

SMi’s Wearable Injectors conference will explore new technologies and advances of on-body devices for the administration of viscous and large molecule drug delivery, and evaluate the impact of IoT, connectivity and enhancement of user-interface which make up core components within the wearable devices field.

This two-day agenda offers you peer-to-peer networking with Global Device Development Managers, Senior Connectivity Engineers, Leaders in Device Data Generation, Human Factors Directors and many more.

PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS
8th October 2019

Cross company collaboration to develop digital therapeutic solutions using connected devices

Digital therapeutics using connected devices are often developed in collaboration between pharma, device and software developers, data platform owners, data providers, wearables and sensor providers and others.

This workshop will focus on:

  • Reviewing the typical scope and component elements of a digital therapeutic    * Key considerations for a successful multi-party collaboration
  • Development of the collaborations of the future

This workshop is intended for those who wish to learn more about:

  • Collaborating with other parties (including pharma and technology providers) to develop digital therapeutic solutions
  • How collaborations are evolving and why

Digby Harris,
Global Category Manager – Digital Therapeutics & Devices, AstraZeneca

Wearable injectors: Envisioning their evolution to address current and future unmet needs

Wearable injectors offer great opportunities to improve the subcutaneous delivery of viscous and large volume drug. However when understanding the plethora of user, clinician, pharmacist and drug company stakeholders’ needs, it is difficult for the current generation of wearable injectors to meet this large array and sometimes conflicting set of requirements.

This workshop will explore how wearable injectors can evolve to meet unmet needs and trends in parenteral biologic drug delivery.
  • To understand the landscape of stakeholders and their needs when considering wearable injectors
  • To managing conflicting needs for such devices
  • Understand trends drivers for innovation for wearable injectors
  • Understanding what new technology developments are required for the next generation of wearable injectors
James Blakemore,
S
enior Consultant & Sergio Marlorni,
Senior Consultant,

Cambridge Consultants

Download the brochure today to see what you could gain from attending Wearable Injectors and Connected Device Conference.

Reserve your seat today to benefit from our £400 early bird saving when you book before 31st May 2019 here

We looking forward to welcoming you in February!

 
CONTACT US:
 To sponsor or exhibit, contact Alia Malick on +44 (0)20 7827 6168
For delegate and group bookings contact Fateja Begum on +44 (0)20 7827 6184

We are contacting you because we believe you have a business interest in this sector
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out
 
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology Europe, a UBM publication. You are on the mailing list as %%emailaddress%%.